The validity of the recommended criteria for termination of the ajmaline test in diagnosing Brugada syndrome.
Meregalli
Paola G
PG
Veltmann
Christian
C
D000404:Ajmaline / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D053840:Brugada Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology; D005189:False Positive Reactions; D006801:Humans; D015203:Reproducibility of Results; D006113:United Kingdom / Q000453:epidemiology
D000889:Anti-Arrhythmia Agents; D000404:Ajmaline